Products
Comprehensive catalog of pharmaceutical solutions. Browse categories and send inquiries directly.
All Products (882)
| Molecule | Drug Class / Mechanism | Oncology Type | Inquiry | |
|---|---|---|---|---|
Peginterferon Alfa-2a |
Interferon / Interleukin | Both (Solid & Hematologic) | ||
|
Molecule
Peginterferon Alfa-2a
Therapeutic Category
Immunotherapy (Cytokine)
Oncology Type
Both (Solid & Hematologic)
Drug Class / Mechanism
Interferon / Interleukin |
||||
Peginterferon Alfa-2b |
Interferon / Interleukin | Both (Solid & Hematologic) | ||
|
Molecule
Peginterferon Alfa-2b
Therapeutic Category
Immunotherapy (Cytokine)
Oncology Type
Both (Solid & Hematologic)
Drug Class / Mechanism
Interferon / Interleukin |
||||
Pemigatinib |
FGFR Inhibitor | Solid Tumour | ||
|
Molecule
Pemigatinib
Therapeutic Category
Targeted Therapy
Oncology Type
Solid Tumour
Drug Class / Mechanism
FGFR Inhibitor |
||||
Penpulimab |
Anti-PD-1 mAb | Both (Solid & Hematologic) | ||
|
Molecule
Penpulimab
Therapeutic Category
Immunotherapy (Checkpoint Inhibitor)
Oncology Type
Both (Solid & Hematologic)
Drug Class / Mechanism
Anti-PD-1 mAb |
||||
Peposertib |
DNA Damage Response Inhibitor (WEE1/ATR/CHK1) | Solid Tumour | ||
|
Molecule
Peposertib
Therapeutic Category
Targeted Therapy
Oncology Type
Solid Tumour
Drug Class / Mechanism
DNA Damage Response Inhibitor (WEE1/ATR/CHK1) |
||||
Pexmetinib |
FLT3 Inhibitor | Hematologic (AML) | ||
|
Molecule
Pexmetinib
Therapeutic Category
Targeted Therapy
Oncology Type
Hematologic (AML)
Drug Class / Mechanism
FLT3 Inhibitor |
||||
PF-06821497 (EZH2 Inhibitor) |
EZH2 Inhibitor | Hematologic | ||
|
Molecule
PF-06821497 (EZH2 Inhibitor)
Therapeutic Category
Targeted Therapy
Oncology Type
Hematologic
Drug Class / Mechanism
EZH2 Inhibitor |
||||
Phosphorus-32 Sodium Phosphate |
Radiotherapeutic / Radiodiagnostic Agent | Both (Solid & Hematologic) | ||
|
Molecule
Phosphorus-32 Sodium Phosphate
Therapeutic Category
Radiopharmaceutical / Nuclear Medicine
Oncology Type
Both (Solid & Hematologic)
Drug Class / Mechanism
Radiotherapeutic / Radiodiagnostic Agent |
||||
Pictilisib |
PI3K Inhibitor | Both (Solid & Hematologic) | ||
|
Molecule
Pictilisib
Therapeutic Category
Targeted Therapy
Oncology Type
Both (Solid & Hematologic)
Drug Class / Mechanism
PI3K Inhibitor |
||||
Piflufolastat F-18 (Diagnostic) |
Radiotherapeutic / Radiodiagnostic Agent | Both (Solid & Hematologic) | ||
|
Molecule
Piflufolastat F-18 (Diagnostic)
Therapeutic Category
Radiopharmaceutical / Nuclear Medicine
Oncology Type
Both (Solid & Hematologic)
Drug Class / Mechanism
Radiotherapeutic / Radiodiagnostic Agent |
||||
Pilaralisib |
PI3K Inhibitor | Both (Solid & Hematologic) | ||
|
Molecule
Pilaralisib
Therapeutic Category
Targeted Therapy
Oncology Type
Both (Solid & Hematologic)
Drug Class / Mechanism
PI3K Inhibitor |
||||
Pimasertib |
BRAF / MEK Inhibitor | Solid Tumour | ||
|
Molecule
Pimasertib
Therapeutic Category
Targeted Therapy
Oncology Type
Solid Tumour
Drug Class / Mechanism
BRAF / MEK Inhibitor |
||||
Peginterferon Alfa-2aImmunotherapy (Cytokine) |
|
|
Therapeutic Category
Immunotherapy (Cytokine)
Oncology Type
Both (Solid & Hematologic)
Drug Class / Mechanism
Interferon / Interleukin |
|
Peginterferon Alfa-2bImmunotherapy (Cytokine) |
|
|
Therapeutic Category
Immunotherapy (Cytokine)
Oncology Type
Both (Solid & Hematologic)
Drug Class / Mechanism
Interferon / Interleukin |
|
PemigatinibTargeted Therapy |
|
|
Therapeutic Category
Targeted Therapy
Oncology Type
Solid Tumour
Drug Class / Mechanism
FGFR Inhibitor |
|
PenpulimabImmunotherapy (Checkpoint Inhibitor) |
|
|
Therapeutic Category
Immunotherapy (Checkpoint Inhibitor)
Oncology Type
Both (Solid & Hematologic)
Drug Class / Mechanism
Anti-PD-1 mAb |
|
PeposertibTargeted Therapy |
|
|
Therapeutic Category
Targeted Therapy
Oncology Type
Solid Tumour
Drug Class / Mechanism
DNA Damage Response Inhibitor (WEE1/ATR/CHK1) |
|
PexmetinibTargeted Therapy |
|
|
Therapeutic Category
Targeted Therapy
Oncology Type
Hematologic (AML)
Drug Class / Mechanism
FLT3 Inhibitor |
|
PF-06821497 (EZH2 Inhibitor)Targeted Therapy |
|
|
Therapeutic Category
Targeted Therapy
Oncology Type
Hematologic
Drug Class / Mechanism
EZH2 Inhibitor |
|
Phosphorus-32 Sodium PhosphateRadiopharmaceutical / Nuclear Medicine |
|
|
Therapeutic Category
Radiopharmaceutical / Nuclear Medicine
Oncology Type
Both (Solid & Hematologic)
Drug Class / Mechanism
Radiotherapeutic / Radiodiagnostic Agent |
|
PictilisibTargeted Therapy |
|
|
Therapeutic Category
Targeted Therapy
Oncology Type
Both (Solid & Hematologic)
Drug Class / Mechanism
PI3K Inhibitor |
|
Piflufolastat F-18 (Diagnostic)Radiopharmaceutical / Nuclear Medicine |
|
|
Therapeutic Category
Radiopharmaceutical / Nuclear Medicine
Oncology Type
Both (Solid & Hematologic)
Drug Class / Mechanism
Radiotherapeutic / Radiodiagnostic Agent |
|
PilaralisibTargeted Therapy |
|
|
Therapeutic Category
Targeted Therapy
Oncology Type
Both (Solid & Hematologic)
Drug Class / Mechanism
PI3K Inhibitor |
|
PimasertibTargeted Therapy |
|
|
Therapeutic Category
Targeted Therapy
Oncology Type
Solid Tumour
Drug Class / Mechanism
BRAF / MEK Inhibitor |
|